ORI Trademark

Trademark Overview


On Tuesday, February 6, 2024, a trademark application was filed for ORI with the United States Patent and Trademark Office. The USPTO has given the ORI trademark a serial number of 98393638. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 18, 2025. This trademark is owned by Oribiotech Limited. The ORI trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations for use in cell culturing, namely, cell culture media for medical or veterinary purposes; chemical preparations for pharmaceutical purposes, namely, for cell and gene therapy; chemical preparations for medical purposes, namely, for cell and gene therapy; biochemical preparations and biological preparations for medical purposes for use in cell culturing, cell therapy; biochemical preparations and biological preparations for use in gene therapy; cell growth media for cell culturing for medical and clinical use, cell therapy; cell growth media for gene therapy; pharmaceuticals, namely, pharmaceutical preparations for use in cell and gene therapy
ori

General Information


Serial Number98393638
Word MarkORI
Filing DateTuesday, February 6, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2025

Trademark Statements


Goods and ServicesChemical preparations for use in cell culturing, namely, cell culture media for medical or veterinary purposes; chemical preparations for pharmaceutical purposes, namely, for cell and gene therapy; chemical preparations for medical purposes, namely, for cell and gene therapy; biochemical preparations and biological preparations for medical purposes for use in cell culturing, cell therapy; biochemical preparations and biological preparations for use in gene therapy; cell growth media for cell culturing for medical and clinical use, cell therapy; cell growth media for gene therapy; pharmaceuticals, namely, pharmaceutical preparations for use in cell and gene therapy
Translation of Words in MarkThe wording "ORI" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOribiotech Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon E149FJ
GB

Party NameOribiotech Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon E149FJ
GB

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024NEW APPLICATION ENTERED
Tuesday, June 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 30, 2024ASSIGNED TO EXAMINER
Saturday, August 31, 2024NON-FINAL ACTION E-MAILED
Saturday, August 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 31, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, November 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 7, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 7, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, January 7, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, January 7, 2025EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED